TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 120 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,493,000 | +179.8% | 33,136 | -0.2% | 0.00% | +200.0% |
| Q1 2022 | $891,000 | -43.7% | 33,190 | +0.1% | 0.00% | -50.0% |
| Q4 2021 | $1,582,000 | -46.9% | 33,168 | -26.0% | 0.00% | -33.3% |
| Q3 2021 | $2,979,000 | -26.1% | 44,838 | -13.2% | 0.00% | -25.0% |
| Q2 2021 | $4,032,000 | -9.8% | 51,684 | +9.3% | 0.00% | -20.0% |
| Q1 2021 | $4,472,000 | -34.1% | 47,276 | -15.1% | 0.01% | -37.5% |
| Q4 2020 | $6,788,000 | +54.5% | 55,706 | +10.8% | 0.01% | +60.0% |
| Q3 2020 | $4,393,000 | +105.9% | 50,281 | +52.2% | 0.01% | +66.7% |
| Q2 2020 | $2,134,000 | +51.6% | 33,036 | +4.8% | 0.00% | +50.0% |
| Q1 2020 | $1,408,000 | -28.3% | 31,536 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,964,000 | +325.1% | 31,536 | +156.9% | 0.00% | +100.0% |
| Q3 2019 | $462,000 | -7.6% | 12,276 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $500,000 | – | 12,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
| MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
| Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
| Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
| Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
| SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
| First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
| Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
| Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |